PubRank

A A Fienberg

Author PubWeight™ 36.19‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Genome-wide expression analysis reveals dysregulation of myelination-related genes in chronic schizophrenia. Proc Natl Acad Sci U S A 2001 6.68
2 Phosphorylation of DARPP-32 by Cdk5 modulates dopamine signalling in neurons. Nature 1999 3.50
3 Synapsins as mediators of BDNF-enhanced neurotransmitter release. Nat Neurosci 2000 2.62
4 Dopamine and cAMP-regulated phosphoprotein 32 kDa controls both striatal long-term depression and long-term potentiation, opposing forms of synaptic plasticity. J Neurosci 2000 1.98
5 DARPP-32 and regulation of the ethanol sensitivity of NMDA receptors in the nucleus accumbens. Nat Neurosci 2002 1.96
6 Regulation of phosphorylation of the GluR1 AMPA receptor in the neostriatum by dopamine and psychostimulants in vivo. J Neurosci 2000 1.84
7 Protein phosphatase 1 modulation of neostriatal AMPA channels: regulation by DARPP-32 and spinophilin. Nat Neurosci 1999 1.81
8 A dopamine/D1 receptor/protein kinase A/dopamine- and cAMP-regulated phosphoprotein (Mr 32 kDa)/protein phosphatase-1 pathway regulates dephosphorylation of the NMDA receptor. J Neurosci 1998 1.50
9 D(2) dopamine receptors induce mitogen-activated protein kinase and cAMP response element-binding protein phosphorylation in neurons. Proc Natl Acad Sci U S A 1999 1.44
10 A network of control mediated by regulator of calcium/calmodulin-dependent signaling. Science 2004 1.42
11 Galpha(olf) levels are regulated by receptor usage and control dopamine and adenosine action in the striatum. J Neurosci 2001 1.20
12 Requirement for DARPP-32 in progesterone-facilitated sexual receptivity in female rats and mice. Science 2000 1.13
13 D(1) dopamine receptor activation reduces GABA(A) receptor currents in neostriatal neurons through a PKA/DARPP-32/PP1 signaling cascade. J Neurophysiol 2000 1.10
14 Neuronal and behavioural abnormalities in striatal function in DARPP-32-mutant mice. Eur J Neurosci 1999 1.05
15 Motivational effects of ethanol in DARPP-32 knock-out mice. J Neurosci 2001 0.97
16 Phosphodiesterase 1B differentially modulates the effects of methamphetamine on locomotor activity and spatial learning through DARPP32-dependent pathways: evidence from PDE1B-DARPP32 double-knockout mice. Genes Brain Behav 2006 0.94
17 Inhibitor-1 is not required for the activation of glycogen synthase by insulin in skeletal muscle. J Biol Chem 1999 0.87
18 Requirement for DARPP-32 in mediating effect of dopamine D2 receptor activation. Eur J Neurosci 1999 0.86
19 DARPP-32 knockout mice exhibit impaired reversal learning in a discriminated operant task. Brain Res 2000 0.85
20 Dopamine D(1) receptor-induced gene transcription is modulated by DARPP-32. J Neurochem 2000 0.83
21 Drugs of abuse modulate the phosphorylation of ARPP-21, a cyclic AMP-regulated phosphoprotein enriched in the basal ganglia. Neuropharmacology 2000 0.83
22 Ovarian function and morphology after deletion of the DARPP-32 gene in mice. Exp Clin Endocrinol Diabetes 2004 0.80
23 Effects of chronic 'Binge' cocaine administration on plasma ACTH and corticosterone levels in mice deficient in DARPP-32. Neuroendocrinology 1999 0.78